Search NASA⌕ Search

SEARCH · Search NASA

Results for “DOSIMETRY”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 91 records · Page 5
All sourcesNASA NTRSDOE OSTI
DOE OSTI2023

Development and testing of a fission-like neutron field for dosimetry and instrument calibrations based on deuterium-tritium generator

For nearly five decades 252 Cf sources have been used for testing and calibration over a wide range of neutron detection devices used for nuclear safety and radiation protection. However, the vastly increased cost of 252 Cf sources, its short half-life, and concerns about future shortage have prompted nuclear facilities and radiological calibration laboratories that rely on high-intensity neutron sources to seek alternatives. There appear to be no other radionuclide neutron sources that would match “like-to-like” 252 Cf performance characteristics. Alternatives of producing a fission-like neutron spectrum based on commercially available deuterium-tritium (D-T) generators, and without any fissionable materials or beryllium, have been explored. This paper describes efforts of designing the spectrum shaping assembly, its construction and installation. The produced neutron field was evaluated both from the perspective of the neutron fluence spectrum and the resulting dosimetric outcome. Finally, it was tested for practical application by examining response of various health physics instruments and personal monitoring devices in comparison to the response of those devices when exposed to 252 Cf. In conclusion, the response of survey-type instruments tested within the prototype, surrogate fission, reference field are acceptably close to their response in the targeted 252 Cf field.

46 INSTRUMENTATION RELATED TO NUCLEAR SCIENCE AND ↗
DOE OSTI2025

Development of a military-specific mesh-type computational phantom library and its application to internal dosimetry and in-field radiological triage screening

Estimates of organ-absorbed and committed doses to individuals exposed to radioactive materials via acute inhalation often rely on internal dose coefficients and detector responses from reference human computational models. To achieve more accurate dose assessments to United States Armed Forces service members exposed in-field, computational models with varying morphometric parameters representative of this population are necessary. The International Commission on Radiological Protection (ICRP) Publication 145 provides detailed mesh reference computational phantoms (MRCPs) for adult males and females, with morphometric parameters matched to the 50th percentile. Previously, these phantoms were 2D and 3D scaled to match desired height, mass, and secondary anthropomorphic parameters in the creation of the University of Florida / Memorial Sloan Kettering (UF/MSK) computational phantom library. To achieve body fat percentage targets required for accession into the US Armed Forces, muscle and fat volumes were adjusted accordingly, thus, creating the UF/Department of Defence computational phantom library presented in this study. A comprehensive library of mesh-type computational human phantoms was created, including 57 adult males and 49 adult females with morphometric parameters aligned with United States Armed Forces service members. Phantoms were restricted to a body mass index between 19 and 27.5, with body fat percentages below 26% for males and 36% for females. Specific absorbed fractions were computed for selected source and target combinations, demonstrating how variations in height and body mass influence energy absorption in target regions relative to the ICRP MRCPs. Radiation detector responses were also computed, revealing that higher body masses resulted in decreased registered counts in the detection volume. These findings highlight the importance of incorporating morphometric variability in computational phantoms to achieve more accurate dose assessments and radiation detection responses for United States Armed Forces service members who inhale radioactive materials in-field.

computational phantoms↗
DOE OSTI2022

Dosimetry and cancer risk estimations for different radiation protection solutions at decommissioning a contaminated nuclear power plant site

Contaminated sediments originating from dredging activities in a nuclear power plant site were placed in a pond, which has to be taken into consideration during the future decommissioning process. The sediments have to be handled to free release the site. The radionuclides Co-60 and Cs-137 were identified and the activity concentrations (Bq/kg) were quantified in the range of 10–6000 and 5–50 Bq kg -1 , respectively. The absorbed dose rate to individuals of various ages and sex present at the site of the dry pond area was estimated. The radiological impact in terms of lifetime attributable risk (LAR) and effective dose were calculated. For a 30-year-old male exposed during one year without any action regarding the sediments in the dried out pond, the LAR was predicted to be 0.0027, which recalculated to effective dose corresponds to 7.6 mSv year -1 . The calculations show that countermeasures will be needed for the contaminated site.

61 RADIATION PROTECTION AND DOSIMETRY↗
DOE OSTI2021

Stochastic parametric skeletal dosimetry model for humans: General approach and application to active marrow exposure from bone-seeking beta-particle emitters

The objective of this study is to develop a skeleton model for assessing active marrow dose from bone-seeking beta-emitting radionuclides. This article explains the modeling methodology which accounts for individual variability of the macro- and microstructure of bone tissue. Bone sites with active hematopoiesis are assessed by dividing them into small segments described by simple geometric shapes. Spongiosa, which fills the segments, is modeled as an isotropic three-dimensional grid (framework) of rod-like trabeculae that “run through” the bone marrow. Randomized multiple framework deformations are simulated by changing the positions of the grid nodes and the thickness of the rods. Model grid parameters are selected in accordance with the parameters of spongiosa microstructures taken from the published papers. Stochastic modeling of radiation transport in heterogeneous media simulating the distribution of bone tissue and marrow in each of the segments is performed by Monte Carlo methods. Model output for the human femur at different ages is provided as an example. The uncertainty of dosimetric characteristics associated with individual variability of bone structure was evaluated. An advantage of this methodology for the calculation of doses absorbed in the marrow from bone-seeking radionuclides is that it does not require additional studies of autopsy material. The biokinetic model results will be used in the future to calculate individual doses to members of a cohort exposed to 89,90 Sr from liquid radioactive waste discharged to the Techa River by the Mayak Production Association in 1949–1956. Further study of these unique cohorts provides an opportunity to gain more in-depth knowledge about the effects of chronic radiation on the hematopoietic system. In addition, the proposed model can be used to assess the doses to active marrow under any other scenarios of 90 Sr and 89 Sr intake to humans.

59 BASIC BIOLOGICAL SCIENCES↗
DOE OSTI2024

IER-484 CED3b Report: AFRRI ER1 Dosimetry Characterization

This report presents the preliminary work for IER 484, the characterization of the leakage radia tion field from the TRIGA reactor at the Armed Forces Radiobiology Research Institute (AFRRI). The purpose of the dose characterization is to establish the reference dose needed to execute a NAD inter-comparison exercise. During the week of August 20th, a team from Lawrence Livermore National Laboratory (LLNL), Sandia National Laboratory (SNL), and Institut de Radioprotection et de Sûreté Nucléaire (IRSN) performed various measurements in AFRRI’s TRIGA ER1 (Exposure Room 1) with Passive Neutron Spectrometer (PNS) spheres and nuclear accident dosimeters (NADs) mounted on Bottle Manikin Absorption (BOMAB) phantoms (to simulate doses received by people) and additional NADs mounted on aluminum plates (to simulate doses in free air). Without Atomic Weapons Establishment (AWE), LLNL became responsible for measuring the neutron spectrum using PNS spheres. SNL is responsible for providing photon dose data. LLNL, SNL, and IRSN each deployed their own NADs, which will be compared to the reference dose measured. Final characterization of the dose field based on analyzed data will be presented in the CED4a report.

42 ENGINEERING↗
DOE OSTI2024

IER-484 CED4a Report: AFRRI ER1 Dosimetry Characterization

This report presents an analytical function as the reference neutron and photon dose (normalized to an ion chamber integral) for future nuclear accident dosimeter (NAD) exercise at the Armed Forces Radiobiology Research Institute (AFRRI). Various dosimeters and equipment were positioned within exposure room 1 (ER1) and irradiated using a 1.1 MW Training, Research, Isotope, General Atomics (TRIGA) Mark-F nuclear reactor. An ion chamber located in ER1 was used as a normalization factor in Equation 2. This allows for a quick calculation of neutron and photon dose based on the ion chamber data. Currently, AFRRI is in preparation to host a NAD exercise this summer.

61 RADIATION PROTECTION AND DOSIMETRY↗
DOE OSTI2025

Updated Results of the Nuclear Accident Dosimetry Intercomparison at the Armed Forces Radiobiology Research Institute’s TRIGA Reactor (IER-602 CED-4a Report)

The IER-602 3b document (Angus, et al. 2024) reported the initial, 24-hour results of the international nuclear accident intercomparison, which took place at the Armed Forces Radiobiological Research Institute during June 24-28, 2024. This report provides updated results and further analysis of the intercomparison.

61 RADIATION PROTECTION AND DOSIMETRY↗
DOE OSTI2022

Positron Emission Intensity in the Decay of 86 gY for Use in Dosimetry Studies

The β + -emitting radionuclide 86 gY (t 1/2 = 14.7 h) forms a matched-pair with the β – -emitting therapeutic radionuclide 90Y (t 1/2 = 2.7 d) for theranostic application in medicine. This approach demands a precise knowledge of the positron emission probability of the PET nuclide which was until recently rather uncertain for 86 gY. In this work, an 86 gY source of high radionuclidic purity was prepared and a direct measurement of the positron emission intensity per 100 decay of the parent (hereafter “positron emission intensity”) was performed using high-resolution HPGe detector γ-ray spectroscopy. The electron capture intensity was also determined as an additional check by measuring the K α and K β X-rays of energies 14.1 and 15.8 keV, respectively, using a low energy HPGe detector. From those measurements, normalized values of 27.2 ± 2.0% for β + -emission and 72.8 ± 2.0% for EC were obtained. These results are in excellent agreement with values recently reported in the literature based on a detailed decay scheme study.

61 RADIATION PROTECTION AND DOSIMETRY↗
DOE OSTI2024

Correlation of As-read and As-run Dosimetry Data

The Nuclear Science Users Facilities (NSUF) is responsible for the coordination of experiments conducted in Advanced Test Reactor (ATR) by Universities and other outside organizations. Completion of the experiment and data reporting process is long and expensive. As such, it is expected that targets for temperature and neutron dosage are met. Simulations of expected reactor performance under specific conditions to meet these targets are critical for this process. However, it is not often that these reports are correlated with the data produced by monitors in ATR. This project aims to correlate simulation and read data from experiments in ATR to gauge uncertainty.

22 GENERAL STUDIES OF NUCLEAR REACTORS↗
DOE OSTI2020

Neutron heating assessment in Minerve reactor by using alanine/ESR dosimetry

In the framework of the ICERR (International Center based on Research Reactors) project, the effect of neutron/gamma irradiation on material and dosimeters has been studied. In this work, we explore the alanine dose-response in the core of the MINERVE research reactor at the CEA Cadarache and we investigate the neutron heating effects in order to evaluate alanine neutron sensitivity. The measured dose of the alanine detector in the mixed gamma-neutron field was estimated by electron spin resonance spectrometry (ESR) with reference to an absorbed dose in water from a 60 Co gamma-ray beam. The experimental sources of uncertainties were reduced by using the optimum conditions of charged-particle equilibrium (CPE), obtained by introducing alanine dosimeters into the aluminum pillbox. Cavity correction factors and dose components were evaluated by the Monte Carlo code MCNP. The calculation showed an underestimated neutron dose with a (C/E) value of about 0.993 +/- 10.83%(k = 1). Results indicate that the fast neutron dose, mainly due to elastic neutron scattering on hydrogen nuclei, represents about 70% of the total dose, while the gamma dose was found to be around 45% of the neutron dose. Additionally, the neutron relative efficiency (REn) to 60 Co gamma-radiation was estimated to be 0.544 +/- 8%(k = 1).

21 SPECIFIC NUCLEAR REACTORS AND ASSOCIATED PLANTS↗
DOE OSTI2021

Translating dosimetry of Dibenzo[ def,p ]chrysene (DBC) and metabolites across dose and species using physiologically based pharmacokinetic (PBPK) modeling

We report that Dibenzo[def,p]chrysene (DBC) is an environmental polycyclic aromatic hydrocarbon (PAH) that causes tumors in mice and has been classified as a probable human carcinogen by the International Agency for Research on Cancer. Animal toxicity studies often utilize higher doses than are found in relevant human exposures. Additionally, like many PAHs, DBC requires metabolic bioactivation to form the ultimate toxicant, and species differences in DBC and DBC metabolite metabolism have been observed. To understand the implications of dose and species differences, a physiologically based pharmacokinetic model (PBPK) for DBC and major metabolites was developed in mice and humans. Metabolism parameters used in the model were obtained from experimental in vitro metabolism assays using mice and human hepatic microsomes. PBPK model simulations were evaluated against mice dosed with 15 mg/kg DBC by oral gavage and human volunteers orally microdosed with 29 ng of DBC. DBC and its primary metabolite DBC-11,12-diol were measured in blood of mice and humans, while in urine, the majority of DBC metabolites were obeserved as conjugated DBC-11,12-diol, conjugated DBC tetrols, and unconjugated DBC tetrols. The PBPK model was able to predict the time course concentrations of DBC, DBC-11,12-diol, and other DBC metabolites in blood and urine of human volunteers and mice with reasonable accuracy. Agreement between model simulations and measured pharmacokinetic data in mice and human studies demonstrate the success and versatility of our model for interspecies extrapolation and applicability for different doses. Furthermore, our simulations show that internal dose metrics used for risk assessment do not necessarily scale allometrically, and that PBPK modeling provides a reliable approach to appropriately account for interspecies differences in metabolism and physiology.

59 BASIC BIOLOGICAL SCIENCES↗
DOE OSTI2025

A physiologically based pharmacokinetic (PBPK) model to align dosimetry of the isobutyl metabolic series in rats and humans

Here, we developed a physiologically based pharmacokinetic (PBPK) model in rats and humans for the isobutyl metabolic series including isobutyl acetate, isobutanol, isobutyraldehyde, and isobutyric acid. Chemical manufactures routinely use these compounds as solvents, for chemical synthesis, as potential biofuels, de-icing fluids, and additives for food and/or fragrance in consumer products. Human exposure to isobutyl compounds can occur through inhalation or oral routes. We previously developed a PBPK model for the propyl metabolic series and utilized it as a framework to create the isobutyl PBPK model due to the chemical similarities between the two series. To support model development, we measured in vitro metabolism of isobutyl acetate in rat and human blood and liver S9 fractions. Compared to rats, humans demonstrated faster isobutyl acetate hydrolysis in liver S9 fractions, while the hydrolysis rates in blood were similar between the two species. We used concentrations of isobutyl compounds measured in air and blood from rats exposed to isobutyl acetate and isobutanol as well as other published data to further parameterize the model. Following exposure to either isobutyl acetate or isobutanol, we observed isobutanol concentrations highest among the isobutyl compounds in the blood of rats. Overall, the model accurately predicts measured time course concentrations of isobutyl acetate, isobutanol, and isobutyric acid in available data in rats and humans. Sensitivity analyses identified alveolar ventilation rates, isobutyl metabolism rates, and cardiac output as the most sensitive parameters affecting concentrations of isobutyl compounds in blood. The isobutyl PBPK model enables comparisons of internal dose metrics across various isobutyl compound exposures and species and allows for calculation of equivalent external exposures that result in the same dose metric. Regulators can employ this PBPK model to predict and align internal dose metrics of isobutyl compounds for risk assessment purposes.

2-methyl-1-propanol↗
DOE OSTI2022

177 Lu and 227 Th Labeled 3,4,3-(LI-1,2-HOPO): characterization, optimized synthesis, biological distribution and dosimetry

Objectives: Interest in targeted radionuclide therapy has greatly increased namely due to the FDA approval of radiotherapeutic drugs such as Lutathera The identification of chelators that can bind diag- nostic and therapeutic radionuclides would allow facile development of agents tailored for personalized medicine. Hydroxypyridinonate (HOPO) derivatives have been demonstrated as effective decorpo- ration agents for actinides owing to their hard oxygen donor atoms and strong complexation. Utilizing these molecules as chelators for potential nuclear medicine agents should allow for radiometals to be effectively sequestered by the ligand. The aim of this work was to evaluate the in vivo stability of 3-4-3-(LI-1,2-HOPO) (HOPO for short) with 177 Lu and 227 Th as potential beta- and alpha-emitting radiothera- peutic complexes, respectively.

62 RADIOLOGY AND NUCLEAR MEDICINE↗